Japan is home to the world’s second largest pharmaceutical market, valued at more than US$90 billion dollars. Japanese life sciences companies are proactively seeking open innovation partners, aiming to strengthen their product pipelines to cope with international competition and address unmet medical needs. Japanese life sciences companies and venture capitalists will be attending BIO2018 to identify international partners whose technologies and products may enhance their portfolios.
The Embassy of Canada in Japan is pleased to organize Japan Session@ BIO2018, featuring major life sciences companies in Japan. Representatives from these companies will present their strategies for in licensing and investment. We hope this will be an efficient venue for your company’s business development during BIO2018, specifically targeting Japanese companies. Looking forward to seeing you at Japan Session@ BIO2018!